Dr. Praveen Kammar
Surgical Oncologist
GI, Colorectal & Peritoneal Cancers
MBBS, MS General Surgery, MCh Surgical Oncology · Tata Memorial Centre
- Experience
- 16+ years
- Speaks
- English · Hindi
Cancers treated
- Gastrointestinal
- Gynaecological
About Dr. Praveen Kammar
Dr. Praveen Kammar is a gastrointestinal, colorectal and peritoneal cancer surgeon who specialises in minimally invasive (keyhole) and robotic surgery. Dr. Kammar also performs cytoreductive surgery, HIPEC and PIPAC, in which chemotherapy is delivered directly inside the abdomen alongside surgery. Dr. Kammar completed an MCh at Tata Memorial Centre and co-founded the Asian Peritoneal Surface Malignancy Group database with Dr. Sanket Mehta.
Treatments offered
Peritoneal & HIPEC
Gastrointestinal
- Colorectal cancer surgery
- Sphincter-preserving rectal surgery
- Robotic & laparoscopic GI surgery
- TAMIS
Career
- SSO Hospitals (Andheri, Ghatkopar), MumbaiSurgical Oncologist · 2020–Present
- Dr L H Hiranandani Hospital, Powai, MumbaiConsultant Surgical Oncologist · 2023–Present
Education & Training
- MCh, Surgical OncologyTata Memorial Centre, Mumbai · 2015
- MS, General SurgeryJSS Medical College, Mysore · 2010
- MBBSJN Medical College, Belgaum (register: RGUHS) · 2005
- MRCSRoyal College of Surgeons, London
- Fellowship, GI-Colorectal Surgery (Ethicon sponsored)Tata Memorial Centre, Mumbai
- Fellowship, Colorectal SurgeryYonsei Cancer Centre, Seoul, South Korea
- Clinical Fellow, Peritoneal Surface Oncology (with Dr. Sanket Mehta)Saifee Hospital, Mumbai
Research & Publications
See publications on PubMed (opens in a new tab)
Led by Dr. Kammar
- 2025Leiomyosarcoma of the Duodenum: A Diagnostic Dilemma (opens in a new tab)Indian J Surg Oncol
- 2024Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study (opens in a new tab)J Gynecol Oncol
- 2023Subcutaneous cellular angiofibroma of arm: A case report (opens in a new tab)J Cancer Res Ther
- 2023High-Risk Peritoneal Mesothelioma: Does Metronomic Chemotherapy Have a Role? (opens in a new tab)Indian J Surg Oncol
- 2023Robotic versus laparoscopic surgery for middle and low rectal cancer (opens in a new tab)Lancet Gastroenterol Hepatol
- 2022Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy (opens in a new tab)Dis Colon Rectum
- 2021Total parietal peritonectomy performed during interval cytoreductive surgery for advanced epithelial serous ovarian cancer results in a low incidence of platinum resistant recurrence- results of a prospective multi-centre study (opens in a new tab)Eur J Surg Oncol
- 2020Delayed Management of Chemoport Complication (opens in a new tab)Indian J Surg Oncol
- 2020Rare tumour of sternum: Resection & reconstruction (opens in a new tab)Indian J Med Res
- 2020Aortic Resection with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Case Report (opens in a new tab)Indian J Surg Oncol
- 2020Impact of delaying surgery after chemoradiation in rectal cancer: outcomes from a tertiary cancer centre in India (opens in a new tab)J Gastrointest Oncol
- 2019Correlation Between Pelvic Peritoneal Disease and Nodal Metastasis in Advanced Ovarian Cancer: Can Intraoperative Findings Define the Need for Systematic Nodal Dissection? (opens in a new tab)Indian J Surg Oncol
- 2019Robotic posterior pelvic exenteration for locally advanced rectal cancer - a video vignette (opens in a new tab)Colorectal Dis
- 2018Complete robotic lateral pelvic node dissection using the da Vinci Xi platform in rectal cancer - a video vignette (opens in a new tab)Colorectal Dis
- 2018Robotic total pelvic exenteration for locally advanced rectal cancer - a video vignette (opens in a new tab)Colorectal Dis
- 2017Ovarian Metastases of Colorectal Origin: Treatment Patterns and Factors Affecting Outcomes (opens in a new tab)Indian J Surg Oncol
Co-authored
- 2026Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients (opens in a new tab)Eur J Surg Oncol
- 2023Bilateral Thoracic Cytoreductive Surgery for Pseudomyxoma Peritonei of Appendiceal Origin (opens in a new tab)Indian J Surg Oncol
- 2023Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies-A report from the Indian HIPEC Registry (opens in a new tab)Indian J Surg Oncol
- 2022Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer (opens in a new tab)Front Oncol
- 2022Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies-a Retrospective Bi-institutional Study (opens in a new tab)Indian J Surg Oncol
- 2021Laparoscopic versus open resection in locally advanced rectal cancers: a propensity matched analysis of oncological and short-term outcomes (opens in a new tab)Colorectal Dis
- 2021Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study (opens in a new tab)BMJ Open
- 2021Greater-omentum lesion-score (GOLS) as a predictor of residual disease in different regions of the peritoneal cavity in patients undergoing interval cytoreductive surgery for advanced ovarian cancer and its potential clinical utility (opens in a new tab)Eur J Surg Oncol
- 2021Limitations of the PRODIGE 7 trial (opens in a new tab)Lancet Oncol
- 2021Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study (opens in a new tab)Ann Surg Oncol
- 2021Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications (opens in a new tab)Eur J Surg Oncol
- 2021Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Patients with Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study (opens in a new tab)Ann Surg Oncol
- 2021Primary Squamous Cell Carcinoma of the Sternum (opens in a new tab)Ann Thorac Surg
- 2021A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer - A study by INDEPSO (opens in a new tab)Eur J Surg Oncol
- 2020Evolution of Robotic Surgery in a Colorectal Cancer Unit in India (opens in a new tab)Indian J Surg Oncol
- 2020Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index (opens in a new tab)Colorectal Dis
- 2020Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications (opens in a new tab)Eur J Surg Oncol
- 2020The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors (opens in a new tab)Ann Surg Oncol
- 2020Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease? (opens in a new tab)Eur J Surg Oncol
- 2019Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study (opens in a new tab)Eur J Surg Oncol
- 2019Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study (opens in a new tab)Indian J Surg Oncol
- 2019Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC-a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2018Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes (opens in a new tab)J Surg Oncol
- 2018Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes (opens in a new tab)J Laparoendosc Adv Surg Tech A
- 2018Robotic lateral pelvic lymph node dissection in rectal cancer - a video vignette (opens in a new tab)Colorectal Dis
- 2017Excision of retroperitoneal germ cell tumor in children: A distinct surgical challenge (opens in a new tab)J Pediatr Surg
Awards & Leadership
- International Career Development ScholarshipAmerican Society of Colon and Rectal Surgeons (ASCRS) · 2021
- Asian Peritoneal Surface Malignancy Group database (with Dr. Sanket Mehta), Asian Peritoneal Surface Malignancy GroupCo-founder